PERINDOPRIL-MEDIS perindopril arginine 5mg film-coated tablet bottle Австралия - английски - Department of Health (Therapeutic Goods Administration)

perindopril-medis perindopril arginine 5mg film-coated tablet bottle

medis pharma pty ltd - perindopril arginine, quantity: 5 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; maltodextrin; glycerol dibehenate; magnesium stearate; sodium starch glycollate type a; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PERINDOPRIL-GX perindopril arginine 5mg film-coated tablet blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

perindopril-gx perindopril arginine 5mg film-coated tablet blister pack

medis pharma pty ltd - perindopril arginine, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; glycerol dibehenate; maltodextrin; colloidal anhydrous silica; sodium starch glycollate type a; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PERINDOPRIL ARGININE ACTAVIS perindopril arginine 5mg film-coated tablet blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

perindopril arginine actavis perindopril arginine 5mg film-coated tablet blister pack

medis pharma pty ltd - perindopril arginine, quantity: 5 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; colloidal anhydrous silica; maltodextrin; glycerol dibehenate; sodium starch glycollate type a; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PERINDOPRIL-VIS perindopril arginine 5mg film-coated tablet bottle Австралия - английски - Department of Health (Therapeutic Goods Administration)

perindopril-vis perindopril arginine 5mg film-coated tablet bottle

medis pharma pty ltd - perindopril arginine, quantity: 5 mg - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; glycerol dibehenate; maltodextrin; lactose monohydrate; sodium starch glycollate type a; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PERINDOPRIL-ZP perindopril arginine 5mg film-coated tablet blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

perindopril-zp perindopril arginine 5mg film-coated tablet blister pack

medis pharma pty ltd - perindopril arginine, quantity: 5 mg - tablet, film coated - excipient ingredients: glycerol dibehenate; maltodextrin; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; sodium starch glycollate type a; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

APX-PERINDOPRIL ARGININE perindopril arginine 2.5 mg tablet bottle Австралия - английски - Department of Health (Therapeutic Goods Administration)

apx-perindopril arginine perindopril arginine 2.5 mg tablet bottle

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: hydrophobic colloidal silica anhydrous; magnesium stearate; sodium starch glycollate; macrogol 6000; lactose monohydrate; maltodextrin; colour - apx-perindopril arginine is indicated for: the treatment of hypertension; and the treatment of heart failure. in such patients it is recommended that apx-perindopril arginine be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of apx-perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Perindopril Arginine/Amlodipine 5/5 APOTEX perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle Австралия - английски - Department of Health (Therapeutic Goods Administration)

perindopril arginine/amlodipine 5/5 apotex perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Perindopril Arginine/Amlodipine 5/10 APOTEX perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

perindopril arginine/amlodipine 5/10 apotex perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-Perindopril Arginine/Amlodipine 10/10 perindopril arginine 10 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 10/10 perindopril arginine 10 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-Perindopril Arginine/Amlodipine 10/5 perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 10/5 perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg; perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.